86 related articles for article (PubMed ID: 26461278)
1. CD36 as a biomarker of atherosclerosis.
Yazgan B; Ustunsoy S; Karademir B; Kartal-Ozer N
Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S10. PubMed ID: 26461278
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E inhibits CD36 scavenger receptor expression in hypercholesterolemic rabbits.
Ozer NK; Negis Y; Aytan N; Villacorta L; Ricciarelli R; Zingg JM; Azzi A
Atherosclerosis; 2006 Jan; 184(1):15-20. PubMed ID: 15979077
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression.
Tang FT; Cao Y; Wang TQ; Wang LJ; Guo J; Zhou XS; Xu SW; Liu WH; Liu PQ; Huang HQ
Eur J Pharmacol; 2011 Jan; 650(1):275-84. PubMed ID: 20854809
[TBL] [Abstract][Full Text] [Related]
4. CD36 expression in peripheral blood mononuclear cells reflects the onset of atherosclerosis.
Yazgan B; Sozen E; Karademir B; Ustunsoy S; Ince U; Zarkovic N; Ozer NK
Biofactors; 2018 Nov; 44(6):588-596. PubMed ID: 28677864
[TBL] [Abstract][Full Text] [Related]
5. The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation.
Harb D; Bujold K; Febbraio M; Sirois MG; Ong H; Marleau S
Cardiovasc Res; 2009 Jul; 83(1):42-51. PubMed ID: 19264766
[TBL] [Abstract][Full Text] [Related]
6. Dietary homocysteine promotes atherosclerosis in apoE-deficient mice by inducing scavenger receptors expression.
Thampi P; Stewart BW; Joseph L; Melnyk SB; Hennings LJ; Nagarajan S
Atherosclerosis; 2008 Apr; 197(2):620-9. PubMed ID: 17950295
[TBL] [Abstract][Full Text] [Related]
7. oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4.
Kiyan Y; Tkachuk S; Hilfiker-Kleiner D; Haller H; Fuhrman B; Dumler I
J Mol Cell Cardiol; 2014 Jan; 66():72-82. PubMed ID: 24239845
[TBL] [Abstract][Full Text] [Related]
8. Human scavenger protein AIM increases foam cell formation and CD36-mediated oxLDL uptake.
Amézaga N; Sanjurjo L; Julve J; Aran G; Pérez-Cabezas B; Bastos-Amador P; Armengol C; Vilella R; Escolà-Gil JC; Blanco-Vaca F; Borràs FE; Valledor AF; Sarrias MR
J Leukoc Biol; 2014 Mar; 95(3):509-20. PubMed ID: 24295828
[TBL] [Abstract][Full Text] [Related]
9. Pitavastatin downregulates expression of the macrophage type B scavenger receptor, CD36.
Han J; Zhou X; Yokoyama T; Hajjar DP; Gotto AM; Nicholson AC
Circulation; 2004 Feb; 109(6):790-6. PubMed ID: 14970117
[TBL] [Abstract][Full Text] [Related]
10. CD36 and macrophages in atherosclerosis.
Collot-Teixeira S; Martin J; McDermott-Roe C; Poston R; McGregor JL
Cardiovasc Res; 2007 Aug; 75(3):468-77. PubMed ID: 17442283
[TBL] [Abstract][Full Text] [Related]
11. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.
Dai XY; Cai Y; Sun W; Ding Y; Wang W; Kong W; Tang C; Zhu Y; Xu MJ; Wang X
Cardiovasc Res; 2014 Feb; 101(2):297-305. PubMed ID: 24253523
[TBL] [Abstract][Full Text] [Related]
12. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M
J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
[TBL] [Abstract][Full Text] [Related]
14. PKCδ signalling regulates SR-A and CD36 expression and foam cell formation.
Lin CS; Lin FY; Ho LJ; Tsai CS; Cheng SM; Wu WL; Huang CY; Lian CH; Yang SP; Lai JH
Cardiovasc Res; 2012 Aug; 95(3):346-55. PubMed ID: 22687273
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals.
Takahashi K; Takeya M; Sakashita N
Med Electron Microsc; 2002 Dec; 35(4):179-203. PubMed ID: 12658354
[TBL] [Abstract][Full Text] [Related]
16. Detection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesicles.
Nie S; Zhang J; Martinez-Zaguilan R; Sennoune S; Hossen MN; Lichtenstein AH; Cao J; Meyerrose GE; Paone R; Soontrapa S; Fan Z; Wang S
J Control Release; 2015 Dec; 220(Pt A):61-70. PubMed ID: 26450668
[TBL] [Abstract][Full Text] [Related]
17. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.
Nagashima M; Watanabe T; Shiraishi Y; Morita R; Terasaki M; Arita S; Hongo S; Sato K; Shichiri M; Miyazaki A; Hirano T
Atherosclerosis; 2010 Sep; 212(1):70-7. PubMed ID: 20684826
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
Bro S
Dan Med Bull; 2009 Nov; 56(4):177-92. PubMed ID: 19939336
[TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.
Verreth W; De Keyzer D; Davey PC; Geeraert B; Mertens A; Herregods MC; Smith G; Desjardins F; Balligand JL; Holvoet P
Br J Pharmacol; 2007 Jun; 151(3):347-55. PubMed ID: 17384667
[TBL] [Abstract][Full Text] [Related]
20. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
